Trials / Completed
CompletedNCT05191251
Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,588 (actual)
- Sponsor
- Brugmann University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The diagnostic performance of the HEMSTOP (Hematoma, hEmorrhage, Menorrhagia, Surgery, Tooth extraction, Obstetrics, Parents) standardized questionnaire collected during the preoperative anesthesia consultation in order to detect a deficit in hemostasis associated with the risk of hemorrhage in pregnant women will be analyzed. The primary aim of the study is to assess the sensitivity and the specificity of the HEMSTOP questionnaire to identity patients with an abnormal first-line hemostasis test requiring further development by performing second-line hemostasis tests. The second aim of the study is to assess the sensitivity and specificity of the HEMSTOP questionnaire in predicting postpartum hemorrhage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HEMSTOP questionnaire | A HEMSTOP questionnaire is obtained during the anesthesia consultation. |
Timeline
- Start date
- 2022-01-13
- Primary completion
- 2022-06-10
- Completion
- 2022-06-30
- First posted
- 2022-01-13
- Last updated
- 2022-07-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05191251. Inclusion in this directory is not an endorsement.